Global Medical REIT Inc.

NYSE: GMRE · Real-Time Price · USD
6.66
-0.09 (-1.33%)
At close: Aug 15, 2025, 3:46 PM

Global Medical REIT Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
37.97M 34.62M 34.95M 34.17M 34.21M 35.07M 32.93M 35.49M 36.32M 36.23M 36.31M 35.41M 33.68M 31.88M 30.31M 29.97M 28.2M 27.32M
Cost of Revenue
7.58M 7.58M 7.2M 7.44M 7.24M 7.38M 6.09M 7.23M 7.22M 7.54M 7.14M 6.68M 6M 5.37M 4.53M 3.97M 3.3M 3.69M
Gross Profit
14.46M 27.01M 27.76M 26.74M 26.98M 27.68M 26.84M 28.26M 29.09M 28.69M 29.17M 28.73M 27.68M 26.5M 25.79M 25.99M 24.9M 23.64M
Operating Income
8.44M 9.56M 6.41M 8.71M 8.4M 9.15M 8.37M n/a 9.86M 10M 10.02M 10.35M 9.23M 9.13M 10.07M 10.22M 9.25M 8.43M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
585K 3.74M 2.94M 3.39M -1.95M 2.31M 551K 4.83M 14.18M 2.17M 1.85M 10.03M 3.83M 4.29M 5.49M 5.37M 4.16M 3.32M
Net Income
655K 3.56M 2.83M 3.25M -1.69M 2.25M 616K 4.59M 13.28M 2.13M -6.22M 8.06M 2.24M 4.12M 5.26M 5.14M 4.01M 3.21M
Selling & General & Admin
6.03M 3.62M 7.71M 4.38M 4.59M 4.45M 4.22M 4.37M 4.46M 3.8M 4.05M 3.96M 4.34M 4.2M 3.93M 3.85M 4.29M 4.38M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a 13.83M 13.64M 13.64M 13.99M 14.08M 14.24M 23.89M 34K 14.89M 15.09M 14.41M 18K 13.18M 32K 16K 61K 24K
Operating Expenses
6.03M 17.45M 21.35M 18.02M 18.58M 18.53M 4.22M 18.56M 19.27M 18.69M 19.14M 18.38M 18.37M 17.38M 16.59M 15.79M 15.71M 15.24M
Interest Expense
8.01M 7.17M 7.57M 7.24M 6.99M 6.89M 6.98M 7.17M 8.47M 8.27M 8.06M 6.96M 5.4M 4.8M 4.81M 4.83M 5.02M 5.04M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
13.61M 25.03M 28.54M 25.46M 25.82M 25.91M 24.56M 35.49M 26.49M 26.23M 26.28M 25.05M 24.37M 22.75M 21.11M 19.77M 19.02M 18.92M
Income Tax Expense
-178K n/a n/a n/a n/a n/a n/a n/a n/a n/a 8.06M n/a 7.02M n/a 228K n/a 156K 112K
Shares Outstanding (Basic)
66.88M 66.87M 66.84M 65.74M 65.59M 65.57M 65.56M 65.56M 65.54M 65.53M 65.52M 65.52M 65.51M 65.3M 64.33M 64.2M 61.19M 52.67M
Shares Outstanding (Diluted)
66.88M 66.87M 66.84M 65.74M 65.59M 65.57M 65.56M 65.56M 65.54M 65.53M 65.52M 65.52M 65.51M 65.3M 64.33M 64.2M 61.19M 52.67M
EPS (Basic)
-0.01 0.03 0.02 0.03 -0.03 0.03 0.01 0.07 0.18 0.03 -0.09 0.12 0.03 0.06 0.08 0.08 0.07 0.06
EPS (Diluted)
-0.01 0.03 0.02 0.03 -0.03 0.03 0.01 0.07 0.18 0.03 -0.09 0.12 0.03 0.06 0.08 0.08 0.07 0.06
EBITDA
23.73M 24.95M 24.4M 24.45M 19.18M 23.43M 21.95M 26.38M 24.67M 25.16M -32.39M 24.77M 22.34M 21.33M -24.18M 21.29M 19.73M 19.33M
EBIT
8.44M 10.9M 10.51M 10.63M 5.04M 9.2M 7.54M 12M 13.59M 13.07M 11.94M 10.49M 9.23M 7.57M 7.61M 10.2M 9.2M 8.5M
Depreciation & Amortization
15.29M 14.05M 13.89M 13.82M 14.14M 14.23M 14.42M 14.37M 14.8M 14.89M 15.09M 14.41M 14.04M 13.18M 12.65M 11.94M 11.41M 10.83M